Simvastatin Reduces Adiponectin Levels and Insulin Sensitivity

NCT00546182 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2007-10-18

No results posted yet for this study

Summary

We hypothesized simvastatin may reduce adiponectin levels and insulin sensitivity in overweight hypercholesterolemic patients.

Conditions

Sponsors & Collaborators

  • Gachon University Gil Medical Center

    lead OTHER

Principal Investigators

  • Kwang K Koh, MD,PhD · Gachon University Gil Medical Center

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00546182 on ClinicalTrials.gov